| Literature DB >> 30804370 |
Jared S Deyarmin1, Molly C McCormley1, Cory D Champagne2, Alicia P Stephan1, Laura Pujade Busqueta1, Daniel E Crocker3, Dorian S Houser2, Jane I Khudyakov4,5.
Abstract
Chronic physiological stress impacts animal fitness by catabolizing metabolic stores and suppressing reproduction. This can be especially deleterious for capital breeding carnivores such as marine mammals, with potential for ecosystem-wide effects. However, the impacts and indicators of chronic stress in animals are currently poorly understood. To identify downstream mediators of repeated stress responses in marine mammals, we administered adrenocorticotropic hormone (ACTH) once daily for four days to free-ranging juvenile northern elephant seals (Mirounga angustirostris) to stimulate endogenous corticosteroid release, and compared blubber tissue transcriptome responses to the first and fourth ACTH administrations. Gene expression profiles were distinct between blubber responses to single and repeated ACTH administration, despite similarities in circulating cortisol profiles. We identified 61 and 12 genes that were differentially expressed (DEGs) in response to the first ACTH and fourth administrations, respectively, 24 DEGs between the first and fourth pre-ACTH samples, and 12 DEGs between ACTH response samples from the first and fourth days. Annotated DEGs were associated with functions in redox and lipid homeostasis, suggesting potential negative impacts of repeated stress on capital breeding, diving mammals. DEGs identified in this study are potential markers of repeated stress in marine mammals, which may not be detectable by endocrine profiles alone.Entities:
Year: 2019 PMID: 30804370 PMCID: PMC6390094 DOI: 10.1038/s41598-019-39089-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Repeated ACTH administration experiment (described in McCormley et al.[12]) and blubber tissue sampling design. ACTH was administered to juvenile elephant seals once every 24 hours for 4 days. Blubber biopsies were collected immediately before ACTH administration (“pre-ACTH”) and 4 hours after ACTH administration (“ACTH response”) on the first and fourth days. RNA isolated from blubber tissue was used for transcriptome sequencing. Seal (color modified, from https://pixabay.com), syringe (from https://pixabay.com), adipose (enhanced contrast, from https://openclipart.org), and microcentrifuge tube (from http://www.clker.com) images were obtained under CC0 1.0 Universal: CC0 1.0 Public Domain Dedication. License: https://creativecommons.org/publicdomain/zero/1.0.
Number of DEGs identified in each pairwise comparison using DESeq 2.
| Comparison name | Pairwise comparison | total | upreg. DEGs | downreg. | annotated unique DEGs |
|---|---|---|---|---|---|
| First ACTH response | Day 1 ACTH response/Day 1 pre-ACTH | 315 | 302 | 13 | 61 |
| Fourth ACTH response | Day 4 ACTH response/Day 4 pre-ACTH | 29 | 21 | 8 | 12 |
| Overall ACTH response | Day 4 ACTH response/Day 1 pre-ACTH | 624 | 479 | 145 | 99 |
| Pre-ACTH comparison | Day 4 pre-ACTH/Day 1 pre-ACTH | 66 | 39 | 27 | 24 |
| ACTH response comparison | Day 4 ACTH response/Day 1 ACTH response | 27 | 23 | 4 | 12 |
DEGs: differentially expressed genes. Annotated unique DEGs: differentially expressed elephant seal homologs of vertebrate proteins with known function, with multiple transcript isoforms collapsed to a single gene.
Experimental data for juvenile elephant seals used in the RNAseq study, including cortisol and aldosterone concentrations measured immediately before and 4 hours following administration of ACTH (pre-ACTH and ACTH response, respectively; from McCormley et al.[12]).
| Subject | Sex | Mass (kg) | ACTH (U/kg) | Day | pre-ACTH cortisol (nM) | ACTH response cortisol (nM) | pre-ACTH aldosterone (pM) | ACTH response aldosterone (pM) |
|---|---|---|---|---|---|---|---|---|
| Seal 2 | M | 119 | 0.17 | 1 | 198.7 | 760.2 | 812.6 | 1465.8 |
| Seal 4 | M | 125 | 0.16 | 1 | 429.1 | 1298.5 | 828.4 | 2000.1 |
| Seal 6 | F | 103 | 0.19 | 1 | 357.9 | 1542.1 | 670.9 | 1251.1 |
| Seal 7 | F | 99 | 0.20 | 1 | 394.6 | 2598.6 | 792.2 | 1415.0 |
ACTH: adrenocorticotropic hormone.
Aldosterone responses to the fourth ACTH administration were significantly enhanced relative to the first (p < 0.05), while cortisol responses to the first and fourth ACTH administrations did not vary in magnitude[12].
Transcriptome assembly metrics.
| Metric | Value |
|---|---|
| Mean (±SD) reads per sample | 26.9 ± 4.2 million |
| Assembled bases | 1,361,692,561 |
| Assembled contigs (transcripts) | 2,031,456 |
| Assembled transcript families | 1,216,779 |
| Annotated transcripts | 372,783 |
| Mean transcript length | 670.3 bp |
| Read mapping rate | 92.40% |
| Complete metazoan BUSCOs | 85.8% |
| Complete and single-copy metazoan BUSCOs | 51.6% |
| Complete and duplicated metazoan BUSCOs | 34.1% |
| Fragmented metazoan BUSCOs | 13.8% |
| Missing metazoan BUSCOs | 0.4% |
BUSCOs: Benchmarking Universal Single-Copy Orthologs. Read mapping rate: percent of sequenced reads mapping as proper pairs back to the assembly.
Figure 2Volcano plots showing log2 fold change (x-axis) and significance (-log10 * adjusted p-value; y-axis) of genes differentially expressed during the overall ACTH response (a), first ACTH response (b), and fourth ACTH response (c). Significantly upregulated and downregulated genes are shown in orange and purple, respectively. Log2 fold-change and significance cutoffs for differential expression were |1| and 0.05, respectively.
Figure 3Volcano plots showing log2 fold change (x-axis) and significance (-log10 * adjusted p-value; y-axis) of genes differentially expressed in the pre-ACTH (a) and ACTH response (b) comparisons. Significantly upregulated and downregulated genes are shown in orange and purple, respectively. Log2 fold-change and significance cutoffs for differential expression were |1| and 0.05, respectively.
Genes differentially expressed in the pre-ACTH comparison (between pre-ACTH samples from day 1 and pre-ACTH samples from day 4).
| Transcript | Log2 FC | Uniprot or NCBI Accession | Gene Name | Pathway/Process |
|---|---|---|---|---|
| TRINITY_DN590927_c3_g12 | 8.41 | GCNT7_PIG | Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7 (GCNT7) | protein glycosylation |
| TRINITY_DN560952_c14_g1 | 5.27 | XP_020935075.1 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 isoform X1 [Sus scrofa] (PFKFB1) | glycolysis and gluconeogenesis, response to GCs |
| TRINITY_DN566526_c4_g1 | 3.00 | XM_008712174.1 | PREDICTED: Ursus maritimus THAP domain containing 8 (THAP8), transcript variant X2, mRNA (THAP8) | transcription factor |
| TRINITY_DN590504_c4_g4 | 2.90 | ACSM1_BOVIN | Acyl-coenzyme A synthetase ACSM1, mitochondrial precursor | fatty acid activation and metabolism |
| TRINITY_DN560507_c9_g1 | 2.69 | HMCS2_HUMAN | Hydroxymethylglutaryl-CoA synthase, mitochondrial precursor (HMGCS2) | ketogenesis |
| TRINITY_DN592323_c1_g1 | 2.41 | TGO1_BOVIN | Transport and Golgi organization protein 1 homolog precursor | vesicular transport, collagen secretion |
| TRINITY_DN578525_c2_g2 | 2.13 | 209L2_MACMU | CD209 antigen-like protein 2 (CD209L2) | immune response |
| TRINITY_DN568360_c2_g1 | 1.91 | KCRU_HUMAN | Creatine kinase U-type, mitochondrial precursor | phosphocreatine synthesis |
| TRINITY_DN591927_c4_g2 | 1.43 | XM_006736873.1 | cysteine dioxygenase type 1 (CDO1) | adipogenesis, taurine biosynthesis, cysteine degradation |
| TRINITY_DN571555_c4_g2 | 1.42 | GPX3_RAT | Glutathione peroxidase 3 precursor (GPX3) | antioxidant response |
| TRINITY_DN572974_c28_g1 | 1.33 | XM_021692420.1 | adiponectin, C1Q and collagen domain containing (ADIPOQ) | fatty acid oxidation, insulin sensitivity |
| TRINITY_DN566880_c2_g2 | 1.20 | HUTH_BOVIN | Histidine ammonia-lyase (HAL) | amino acid degradation |
| TRINITY_DN592891_c7_g1 | 1.13 | MGST1_PIG | Microsomal glutathione S-transferase 1 (MGST1) | antioxidant response |
| TRINITY_DN575636_c4_g1 | −1.30 | ZBT46_MOUSE | Zinc finger and BTB domain-containing protein 46 | transcriptional repression, immune cell development |
| TRINITY_DN576776_c0_g1 | −2.02 | ITA2_HUMAN | Integrin alpha-2 precursor | ECM organization, cell-matrix adhesion |
| TRINITY_DN545745_c4_g5 | −2.06 | FMOD_HUMAN | Fibromodulin precursor (FMOD) | collagen fibril formation |
| TRINITY_DN57258 _c0_g6 | −2.42 | HBA_ODORO | Hemoglobin subunit alpha | oxygen transport |
FC: fold change (day 4 pre-ACTH/day 1 pre-ACTH); adjusted p < 0.05.
Genes differentially expressed in the ACTH response comparison (between ACTH response samples from day 1 and ACTH response samples from day 4).
| Transcript ID | Log2 FC | Uniprot or NCBI Accession | Gene Name | Pathway/Process |
|---|---|---|---|---|
| TRINITY_DN551341_c9_g1 | 1.94 | GLRA2_RAT | Glycine receptor subunit alpha-2 (GLRA2) | glycine receptor |
| TRINITY_DN570625_c1_g4 | 1.81 | ATS16_HUMAN | A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAMTS16) | blood pressure regulation |
| TRINITY_DN587322_c7_g1 | 1.23 | PIAS4_HUMAN | E3 SUMO-protein ligase PIAS4 (PIAS4) | protein sumoylation, cell stress response, metabolic homeostasis |
| TRINITY_DN592677_c7_g3 | 1.18 | XM_022511147.1 | Perilipin 1 (PLIN1) | lipolysis regulation, insulin sensitivity |
| TRINITY_DN549777_c0_g1 | 1.09 | PLIN4_HUMAN | Perilipin-4 (PLIN4) | triacylglyceride packaging |
| TRINITY_DN587150_c2_g2 | 1.06 | ZA2G_BOVIN | Zinc-alpha-2-glycoprotein (AZGP1) | lipid mobilization |
| TRINITY_DN591317_c4_g2 | 1.04 | ACSL1_MOUSE | Long-chain-fatty-acid–CoA ligase 1 (ACSL1) | fatty acid catabolism, fatty acid synthesis |
| TRINITY_DN587426_c4_g1 | 1.02 | CIDEA_MOUSE | Cell death activator CIDE-A (CIDEA) | lipolysis regulation, insulin sensitivity |
| TRINITY_DN591034_c2_g1 | −1.96 | BGH3_PIG | Transforming growth factor-beta-induced protein ig-h3 (TGFBI) | cell adhesion, adipogenesis |
| TRINITY_DN589692_c4_g2 | −2.82 | XM_002919434.3 | PREDICTED: Ailuropoda melanoleuca C1q and tumor necrosis factor related protein 3, mRNA (C1QTNF3) | inhibition of gluconeogenesis and inflammation |
FC: fold change (day 4 ACTH response/day 1 ACTH response); adjusted p < 0.05.
Figure 4Predicted protein-protein interaction (PPI) network (p < 0.05) for genes differentially expressed over the course of the experiment (overall ACTH response). Upregulated and downregulated genes are shown in orange and purple, respectively.